It is reported that SATB1 binding to the enhancer of Sfpi1 resulted in reduced PU.1 expression in myeloid progenitor cells, which indicated that SATB1 dysfunction is associated with a subset of human AML patients [25]. This evidence concerns the gene SATB1 and acute myeloid leukemia.